Citation 102785

BOYD,MR: CARDELLINA II,JH: MANFREDI,KP: BLUNT,JW: PANNELL,LK: MC MAHON,JB: GULAKOWSKI,RJ: CRAGG,GM: BRINGMANN,G: THOMAS,D: JATO,J:. (1995). MICHELLAMINE ANTIVIRAL AGENTS, COMPOSITIONS, AND TREATMENT METHODS.. ()

Citation Details

Title	MICHELLAMINE ANTIVIRAL AGENTS, COMPOSITIONS, AND TREATMENT METHODS.
Authors	BOYD,MR: CARDELLINA II,JH: MANFREDI,KP: BLUNT,JW: PANNELL,LK: MC MAHON,JB: GULAKOWSKI,RJ: CRAGG,GM: BRINGMANN,G: THOMAS,D: JATO,J:
Year	1995
Volume
Issue

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Ancistrocladus korupensis (ANCISTROCLADACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAPATENT DESCRIBEDCD SPECTRUM REPORTED FOR	MICHELLAMINE A	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE A	WEAK ACTIVITY
3	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED	MICHELLAMINE A	INACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE A	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAPATENT DESCRIBEDCD SPECTRUM REPORTED FOR	MICHELLAMINE B	None
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE B	WEAK ACTIVITY
7	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED	MICHELLAMINE B	INACTIVE
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE B	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFABSOLUTE CONFIGURATION DETERMINEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDPATENT DESCRIBEDCD SPECTRUM REPORTED FOR	MICHELLAMINE C	None
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE C	WEAK ACTIVITY
11	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED	MICHELLAMINE C	INACTIVE
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MICHELLAMINE C	WEAK ACTIVITY

Show SPARQL Queries (1)